The First Affiliated Hospital of Xiamen University: all 118 studies

Page 1 of 2. Open to participants first (79), then studies with results posted, then the rest; newest registration first within each.

• 68Ga-XHER2 PET/CT for HER2 AssessmentRecruitingNCT07885436Not applicable
• 68Ga-XMFH01 PET/Fluorescence Imaging in Prostate CancerRecruitingNCT07885423Not applicable
• Anxiety and Depression in Patients With Hematologic MalignanciesRecruitingNCT07883070
• Venetoclax, Chidamide, and Chiglitazar Sodium (VCC) in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07783100Phase 2
• Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCLRecruitingNCT07778212Not applicable
• Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid CancerRecruitingNCT07753499Not applicable
• Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCLRecruitingNCT07749365Phase 2
• DLL3-Targeted PET/CT in Small Cell Lung CancerRecruitingNCT07677787Not applicable
• GPC3-Targeted PET/CT in Hepatocellular CarcinomaRecruitingNCT07677774Not applicable
• Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles for the Treatment of Dry Eye DiseaseRecruitingNCT07623382Early Phase 1
• Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye DiseaseRecruitingNCT07547930Phase 2
• Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel CancerNot yet recruitingNCT07486492Early Phase 1
• DLL3-Targeted PET/CT in Neuroendocrine CarcinomaRecruitingNCT07458906Not applicable
• Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid TumorsNot yet recruitingNCT07438093Not applicable
• 68Ga-XACP3 PET/CT in Prostate CancerRecruitingNCT07242014Not applicable
• Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine TherapyNot yet recruitingNCT07189884Phase 1/2
• The Effect of Semaglutide on Bone HealthNot yet recruitingNCT07165158Phase 4
• PET/CT for Trop2 ADC Response Evaluation NSCLCRecruitingNCT07151898
• Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal CarcinomaRecruitingNCT07137052
• Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy RegimenNot yet recruitingNCT07137039Phase 2
• the Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction After Urological Laparoscopic SurgeryRecruitingNCT07133620Not applicable
• Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPCRecruitingNCT07085234Phase 2
• 68Ga-MY6349 PET/CT in Solid TumorsRecruitingNCT07046702
• PET/CT for Trop2 ADC Response Evaluation CancersRecruitingNCT07046689
• T-cell Developmental Status in Patients With Malignant Hematological TumorsRecruitingNCT07035938
• A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung CancerNot yet recruitingNCT07031154Phase 2
• Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous CarcinomaNot yet recruitingNCT07019181Phase 2
• Ultrasound Assessment of Fetal Growth ParametersEnrolling by invitationNCT07018362
• Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT06992739Phase 2
• Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer PatientsRecruitingNCT06956144
• Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLCRecruitingNCT06929936Phase 2
• GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHLRecruitingNCT06875063Phase 1
• Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AMLRecruitingNCT06827899Phase 2
• Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular LymphomaRecruitingNCT06826118Phase 2
• Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPCRecruitingNCT06811844Phase 2
• A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery TreatmentRecruitingNCT06757023
• 68Ga-NK224 PET Imaging of PD-L1 Expression in CancersRecruitingNCT06754345
• Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AMLRecruitingNCT06737523Phase 1
• A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate CancerRecruitingNCT06696326Not applicable
• IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal CarcinomaEnrolling by invitationNCT06688175Phase 2
• SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of ImmunotherapyRecruitingNCT06676722Phase 2
• Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML PatientsRecruitingNCT06651866Phase 1
• Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCLRecruitingNCT06651853Phase 2
• Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological TumorsRecruitingNCT06584006Phase 2
• Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple MyelomaRecruitingNCT06581640Phase 2
• Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular LymphomaRecruitingNCT06553352Phase 2
• Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in ChildrenRecruitingNCT06530004
• Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local TherapyRecruitingNCT06478472Not applicable
• A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT06415669Phase 2
• Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)RecruitingNCT06387056Phase 2
• To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate CancerRecruitingNCT06385847Phase 2
• Effect of Oliceridine on Rebound PainRecruitingNCT06382896
• Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive ExpressionRecruitingNCT06375564Phase 1
• Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base SurgeryRecruitingNCT06282224Not applicable
• Dexmedetomidine Premedication for Post-anaesthesia Sleep DisturbanceNot yet recruitingNCT06281561Phase 3
• Efficacy and Safety Evaluation of Prebiotics Combined With Quadruple Probiotics in Improving Functional Constipation.Enrolling by invitationNCT06277505Not applicable
• Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian CancerNot yet recruitingNCT06188455Phase 3
• All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple MyelomaRecruitingNCT06158412Phase 2
• AZA Combined With RCHOP in P53-mutated DLBCL.RecruitingNCT06158399Phase 2
• Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular LymphomaRecruitingNCT06158386Phase 2
• 68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.RecruitingNCT06151119
• Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell LymphomaRecruitingNCT06151106Phase 2
• Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FLRecruitingNCT06151080Phase 2
• Mobile Internet Healthcare and Three Disciplines Co-management Intervention for Overweight/Obese Prediabetic PatientsRecruitingNCT06147752Not applicable
• Graves' Disease Remission Study: MycoMeth ComboRecruitingNCT06068179Phase 2/3
• Characterizing Spondyloarthritis With 68Ga-FAPI PET/CTRecruitingNCT05999643Not applicable
• Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular CarcinomaRecruitingNCT05970666Phase 2
• Characterizing Myositis With 68Ga-FAPI PET/CTRecruitingNCT05952531Early Phase 1
• 68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDGRecruitingNCT05873777Not applicable
• Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN)RecruitingNCT05841615Not applicable
• A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian CancerRecruitingNCT05824247
• VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)RecruitingNCT05603884Phase 2
• Real-World Study on Long-term Treatment With YISAIPU for Fujian RA PatientsRecruitingNCT05424393
• Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AMLRecruitingNCT05305859Phase 2
• Diabetic Complications and Obstructive Sleep ApneaRecruitingNCT04646941
• Comparison of FDG and FAPI in Patients With Various Types of CancerRecruitingNCT04416165Not applicable
• A Prospective Nurse Cohort Study in Xiamen, ChinaRecruitingNCT03799653
• Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After RemissionRecruitingNCT03425812Not applicable
• Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)RecruitingNCT03087032Phase 4
• Comparative Diagnostic Yield of Contrast-Enhanced Versus Conventional Ultrasound Guidance for Coaxial Biopsy of Hepatic LesionsCompletedNCT07249268
• 68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma PatientsCompletedNCT07139054
• Association Between Peri-procedural Myocardial Injury and Quantitative Blood Flow RatioCompletedNCT07110298
• Study on the Effective Dose and Safety of Esketamine in Hysteroscopic Surgery Under Monitored Anesthesia CareActive, not recruitingNCT07034963Phase 1/2
• Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal AblationActive, not recruitingNCT07034950Phase 1/2
• The Relationship Between FAPI Results and Myocardial Fibrosis After Acute Myocardial InfarctionCompletedNCT06841549
• ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid CancerTerminatedNCT06465017Not applicable
• Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT06377683Phase 1
• ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid TumorsCompletedNCT06188468Not applicable
• Difference Between Mean Gestational Sac Diameter and Crown-rump Length as a Marker of First-trimester Pregnancy Outcome in Patients With Recurrent Spontaneous AbortionCompletedNCT06081556
• APA on Sleep Quality in Women With PCOSCompletedNCT06009172Not applicable
• Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Various Solid TumorsCompletedNCT05963386Phase 2
• Individualized Precision Treatment Based on Ovarian Cancer Organoid ModelStatus unknownNCT05813509Not applicable
• 68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDGCompletedNCT05543317Not applicable
• Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CTCompletedNCT05430841Not applicable
• Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid CancerCompletedNCT05410821Phase 1
• Evaluation of 177Lu-TATE-EB-01（LNC1010）in SSTR2-positive TumorsCompletedNCT05410743Phase 1/2
• Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of CancerCompletedNCT05392205Not applicable
• 68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in CancersCompletedNCT05346276
• Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRCStatus unknownNCT05292417Phase 2
• A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard TherapyStatus unknownNCT05287386Phase 2

← The First Affiliated Hospital of Xiamen University overview and focus areas